ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Biosenic Sa

Biosenic Sa (0R55)

3.845
0.00
(0.00%)
Closed July 26 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
3.845
Bid
3.75
Ask
3.94
Volume
1,372
0.00 Day's Range 0.00
3.845 52 Week Range 3.845
Market Cap
Previous Close
3.845
Open
-
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
24,499
Shares Outstanding
163,181,000
Dividend Yield
-
PE Ratio
-0.06
Earnings Per Share (EPS)
-0.18
Revenue
545k
Net Profit
-28.78M

About Biosenic Sa

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Mont-saint-guibert, Walloon Brabant, Bel
Founded
1970
Biosenic Sa is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0R55. The last closing price for Biosenic was 3.85 €. Over the last year, Biosenic shares have traded in a share price range of 3.845 € to 3.845 €.

Biosenic currently has 163,181,000 shares outstanding. The market capitalization of Biosenic is 627.43 € million. Biosenic has a price to earnings ratio (PE ratio) of -0.06.

0R55 Latest News

BioSenic S.A. : Notification de transparence reçue de la part de Monsieur François Rieger

BioSenic S.A. : Notification de transparence reçue de la part de Monsieur François Rieger   COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Article 14 de la loi du 2 mai 2007 relative à la...

BioSenic S.A. : Transparency notification received from Mr François Rieger

BioSenic S.A. : Transparency notification received from Mr François Rieger PRESS RELEASE – REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings...

BioSenic réalise une nouvelle analyse approfondie de ses données cliniques positives de phase 2 en vue d'un schéma d'administration optimal pour son prochain essai clinique de phase avancée sur le trioxyde d'arsenic (ATO) ciblant la cGvHD

BioSenic réalise une nouvelle analyse approfondie de ses données cliniques positives de phase 2 en vue d'un schéma d'administration optimal pour son prochain essai clinique de phase...

BioSenic releases new in-depth analysis of its positive phase 2 clinical data for optimal administration scheme for its next late-stage trial of arsenic trioxide (ATO) targeting cGvHD

BioSenic releases new in-depth analysis of its positive phase 2 clinical data for optimal administration scheme for its next late-stage trial of arsenic trioxide (ATO) targeting cGvHD Press...

BioSenic S.A. : Transparency notification received from Véronique Pomi  

BioSenic S.A. : Transparency notification received from Véronique Pomi   PRESS RELEASE – REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings...

BioSenic S.A. : Notification de transparence reçue de la part de Véronique Pomi

BioSenic S.A. : Notification de transparence reçue de la part de Véronique Pomi   COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Article 14 de la loi du 2 mai 2007 relative à la publicité des...

Medsenic, subsidiary of BioSenic SA, extends key patent to the United States

Medsenic, subsidiary of BioSenic SA, extends key patent to the United States PRESS RELEASE – PRIVILEGED INFORMATION  The developed Medsenic’s composition-of-matter patent family does cover...

Medsenic, BioSenic’s subsidiary, signed a new set of licensing and commercialization agreements with Phebra PTY Ltd.

Medsenic, BioSenic’s subsidiary, signed a new set of licensing and commercialization agreements with Phebra PTY Ltd. PRESS RELEASE – PRIVILEGED INFORMATION  The adapted supply and...

BioSenic S.A. : Information on the total number of voting rights and shares

BioSenic S.A. : Information on the total number of voting rights and shares PRESS RELEASE – REGULATED INFORMATION Mont-Saint-Guibert, Belgium, June 28, 2024, 7.00 am CET – BIOSENIC...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1003.8453.8453.845295253.845DE
4003.8453.8453.845178303.845DE
12003.8453.8453.845244993.845DE
26003.8453.8453.845160403.845DE
52003.8453.8453.845261293.845DE
156003.8453.8453.845132023.845DE
260003.8453.8453.845123373.845DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
POAIPredictive Oncology Inc
$ 1.8696
(74.73%)
149.56M
SLRXSalarius Pharmaceuticals Inc
$ 3.2996
(54.19%)
31.1M
PBMPsyence Biomedical Ltd
$ 0.5865
(49.85%)
77.02M
NVNINVNI Group Ltd
$ 1.75
(44.63%)
4.12M
CMAXCareMax Inc
$ 5.60
(44.33%)
23.45M
TWOU2U Inc
$ 1.51
(-63.35%)
5.1M
XPONExpion360 Inc
$ 0.56
(-46.15%)
1.29M
KDLYKindly MD Inc
$ 1.97
(-38.82%)
821.97k
MXLMaxLinear Inc
$ 14.02
(-37.10%)
7.43M
CTNTCheetah Net Supply Chain Service Inc
$ 0.3047
(-36.78%)
12.79M
NVDANVIDIA Corporation
$ 112.28
(-1.72%)
447.63M
SQQQProShares UltraPro Short QQQ
$ 9.37
(3.42%)
244.13M
SLNASelina Hospitality PLC
$ 0.03755
(-17.83%)
177.23M
POAIPredictive Oncology Inc
$ 1.8696
(74.73%)
149.56M
TSLATesla Inc
$ 220.25
(1.97%)
96.7M

Discussion

View Full Feed
One11 One11 3 minutes ago
Which mm are you talking about? I didn't look today..
MGON
3331 3331 3 minutes ago
Bioelectronics (BIEL): Golden Cross and Blue Skies Breakout Imminent!
The 50 dma is .0001, 200 dma is .0002, yearly high is .0005.
Profitabity: BIEL has cut costs to the bone, such that about $1.5 million annual revenue should make them profitable - they are close, if not already ther
axelvento axelvento 4 minutes ago
UK preparing 'public health response' after H5N1 virus jumps from mammals to humans in pandemic escalation

https://www.gbnews.com/health/bird-flu-pandemic-symptoms-2024-vaccine
MRNA
Tom turtles Tom turtles 7 minutes ago
Maybe today we hit a buck ?
TIVC
janice shell janice shell 8 minutes ago
On December 14, 2018, the White House announced that Mick Mulvaney would replace John Kelly as the White House Chief of Staff.[58]

Mulvaney?

Three years later, Mulvaney says that listening to his former colleagues’ testimonies to the House January 6 committee “makes me
DKLN DKLN 8 minutes ago
For almost two years, the financial documents of this "company" have shown zippo revenue. Therefore, it can be assumed that the sales are not real until/unless the revenue shows up in these documents. There is almost no buying because most potential investors are making that assumption.
MCIC
searay2701 searay2701 9 minutes ago
I thought by now we would have heard or seen something had really changed with EVSV but so far, with being that a few months have gone by, it looks like it’s things as usual with this company. MOO
EVSV
wrinklesobw wrinklesobw 9 minutes ago
No one cares
RDGL
Tom turtles Tom turtles 9 minutes ago
Um...what's up with the five 00000s again ?
RNVA
Rdizz23 Rdizz23 10 minutes ago
There is nothing wrong with being realistic, years ago the entire board was so optimistic, but it's been 7+ years, it's hard to keep being optimistic when we keep getting told another month or another quarter or next year or we are planning to uplist. And on top of that it's been a year and a half s
ALRTF
hap0206 hap0206 11 minutes ago
And I would show you the thousands of graves in France, Italy -- thousands of americans who gave their lives to save those NATO members pushing welfare programs depending on the USA to save their asses one more time -- Trump said get your heads out of your -- -- hope they do in time -- Putin is pla
Tom turtles Tom turtles 11 minutes ago
Valuation means nothing down here in the sewer. It's all about dilution, offerings and stealing as much money as you can off of shareholders. Market Cap...? Too funny. They are obviously going for the RS here. See you at $4 . I'll be ready to short this pig back down again.
FOXO
karmakaziXpert karmakaziXpert 12 minutes ago
Things must be bad y’all. Really bad.

Think about audits, registration statements and fiduciary duties.

Don’t want to have to deal with questions, concerning a public company’s filing, similar to this, when you just started a side company.

Maybe the co
SNPW
RickNagra RickNagra 12 minutes ago
Oh wow. $10 on deck. Oh boy oh girl.
DBMM
IceCold8 IceCold8 13 minutes ago
$SWRM Christopher bailey and his call center scamming diamond in the middle,thank you come again 7-eleven operating snake oil salesman are doing nothing more than shorting $SWRM and lining their wallets. R/S is on the horizon.
SWRM
BDEZ BDEZ 13 minutes ago
From Elon https://x.com/elonmusk/status/1816357504076448006
BDEZ BDEZ 13 minutes ago
Pretty much...
horselover45 horselover45 13 minutes ago
Would be interesting and profitable to reach 15.Def been a while.
CDMO
BigMoneyChalupa BigMoneyChalupa 14 minutes ago
No facts, just opinion. What I state you can verify with facts. Sharp in fact has not diluted shareholders. Sharp has not given up on a deal. Shareholders such as myself have thought about this as an INVESTMENT long-term, forgetting the noise. Try a profitable position well under .02 because I’ve st
WNFT
JJnard JJnard 14 minutes ago
Hiru Corporation Stock Forecast


https://stockinvest.us/stock/HIRU
HIRU
palaypu0406 palaypu0406 14 minutes ago
Dear Laxmifraud,
I am a very open book and I maintain issues very transparently on any matter and I have put myself from 1984 - 2021 on LinkedIn as my response.
Nothing is done under the law or in darkness or shade...

Anything from anywhere, ask respectfully and my resp
ITUP
ihorchu ihorchu 14 minutes ago
Hasn't Musk taking over NNRX been finalized yet???
NNRX
Acme Investments Acme Investments 15 minutes ago
The AI was oversold just like every other fad!! No one knows what the true worth is!! Time for it to come back to earth 🌎!!
MU
janice shell janice shell 16 minutes ago
Thank you for providing yet more information from Kelly, who is a Republican.

But I have no idea what your point is. Kelly told the truth. You know, like Tillerson, McMaster, Mattis, Esper, Milley, and many more who ended up despising him, and considering him dangerous.

Your Recent History

Delayed Upgrade Clock